Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 4 weeks or older, of any sex, race, or ethnicity, who have a personal history of melanoma (a type of skin cancer) that is unusual in its type, pattern, or number of occurrences, diagnosed at any age
- People with known or suspected factors that may increase their risk of melanoma, such as certain genetic or physical conditions present from birth (for example, large birthmarks called giant congenital nevi, abnormal moles called dysplastic nevi, or certain unusual skin growths called Spitzoid tumors)
- People with unusual personal health history features that may be linked to higher melanoma risk, such as being very young at diagnosis, having had multiple melanomas, or having a history of heritable retinoblastoma, Hodgkin's disease, lymphoma, a weakened immune system, or an organ transplant
- People who do not personally have melanoma but have a family history of melanoma that is unusual in type, pattern, or number
- People without melanoma who have family members with the risk factors or unusual health history features listed above
- People who are able to understand and agree to participate, or whose parent or legal guardian is able to understand and agree on their behalf
- Personal and family medical history must be able to be confirmed through questionnaires, interviews, medical records, and review of tissue samples
Who may not be able to join:
- People or families whose reported diagnoses cannot be confirmed through medical records or other verification
- People who are unable to provide informed consent, and for whom a parent or legal guardian is also unable to provide consent on their behalf
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael R Sargen, M.D., National Cancer Institute (NCI)
Phone: (800) 518-8474
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All cancers that occur in individuals and families at high risk of melanoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.